Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pranav Shah

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Frontiers in Pharmacology|December 18, 2023
Development and validation of PAMPA-BBB QSAR model to predict brain penetration potential of novel drug candidatesRintaro Kato, Wenyu Zeng, Vishal B Siramshetty, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 16, 2016
An Automated High-Throughput Metabolic Stability Assay Using an Integrated High-Resolution Accurate Mass Method and Automated Data Analysis SoftwarePranav Shah, Edward Kerns, Dac-Trung Nguyen, et al.
Archives of Toxicology|April 18, 2022
Identification of environmental chemicals that activate p53 signaling after in vitro metabolic activationMasato Ooka, Jinghua Zhao, Pranav Shah, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2018
Discovery and lead identification of quinazoline-based BRD4 inhibitorsShyh-Ming Yang, Daniel J Urban, Makoto Yoshioka, et al.
Cancer Chemotherapy and Pharmacology|March 19, 2020
Metabolism and pharmacokinetics characterization of metarrestin in multiple speciesElias C Padilha, Pranav Shah, Amy Q Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2026
The low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virusTomoyuki Shiota, Yuguang Zhao, Itoe Shiota, et al.
Bioorganic & Medicinal Chemistry|January 14, 2022
Using in vitro ADME data for lead compound selection: An emphasis on PAMPA pH 5 permeability and oral bioavailabilityJordan Williams, Vishal Siramshetty, Ðắc-Trung Nguyễn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 29, 2021
Development of Robust Quantitative Structure-Activity Relationship Models for CYP2C9, CYP2D6, and CYP3A4 Catalysis and InhibitionEric Gonzalez, Sankalp Jain, Pranav Shah, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2025
Optimization of IRAK1/4/pan-FLT3 kinase inhibitors as treatments for acute myeloid leukemiaPatrick J Sutter, Morgan M Walker, Chris J Finocchio, et al.
Journal of Medicinal Chemistry|March 28, 2020
Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC InhibitorsAshish Thakur, Gregory J Tawa, Mark J Henderson, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Frontiers in Pharmacology|December 18, 2023
Development and validation of PAMPA-BBB QSAR model to predict brain penetration potential of novel drug candidatesRintaro Kato, Wenyu Zeng, Vishal B Siramshetty, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 16, 2016
An Automated High-Throughput Metabolic Stability Assay Using an Integrated High-Resolution Accurate Mass Method and Automated Data Analysis SoftwarePranav Shah, Edward Kerns, Dac-Trung Nguyen, et al.
Archives of Toxicology|April 18, 2022
Identification of environmental chemicals that activate p53 signaling after in vitro metabolic activationMasato Ooka, Jinghua Zhao, Pranav Shah, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2018
Discovery and lead identification of quinazoline-based BRD4 inhibitorsShyh-Ming Yang, Daniel J Urban, Makoto Yoshioka, et al.
Cancer Chemotherapy and Pharmacology|March 19, 2020
Metabolism and pharmacokinetics characterization of metarrestin in multiple speciesElias C Padilha, Pranav Shah, Amy Q Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2026
The low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virusTomoyuki Shiota, Yuguang Zhao, Itoe Shiota, et al.
Bioorganic & Medicinal Chemistry|January 14, 2022
Using in vitro ADME data for lead compound selection: An emphasis on PAMPA pH 5 permeability and oral bioavailabilityJordan Williams, Vishal Siramshetty, Ðắc-Trung Nguyễn, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 29, 2021
Development of Robust Quantitative Structure-Activity Relationship Models for CYP2C9, CYP2D6, and CYP3A4 Catalysis and InhibitionEric Gonzalez, Sankalp Jain, Pranav Shah, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2025
Optimization of IRAK1/4/pan-FLT3 kinase inhibitors as treatments for acute myeloid leukemiaPatrick J Sutter, Morgan M Walker, Chris J Finocchio, et al.
Journal of Medicinal Chemistry|March 28, 2020
Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC InhibitorsAshish Thakur, Gregory J Tawa, Mark J Henderson, et al.
Pageof 12